AbbVie Inc.
ABBV· NYSE
AbbVie Inc.
- Last sale
- Oct 1, 2026 · -0.73%
- Market cap
- $459.33B
- 1.77B shares
- Filings
- 1,031
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $61,160,000,000 | reported | |
| FY 2024 | 2024-12-31 | $56,334,000,000 | reported | |
| FY 2023 | 2023-12-31 | $54,318,000,000 | reported | |
| FY 2022 | 2022-12-31 | $58,054,000,000 | reported | |
| FY 2021 | 2021-12-31 | $56,197,000,000 | reported | |
| FY 2020 | 2020-12-31 | $45,804,000,000 | reported | |
| FY 2019 | 2019-12-31 | $33,266,000,000 | reported | |
| FY 2018 | 2018-12-31 | $32,753,000,000 | reported | |
| FY 2017 | 2017-12-31 | $28,216,000,000 | reported | |
| FY 2016 | 2016-12-31 | $25,638,000,000 | reported | |
| FY 2015 | 2015-12-31 | $22,859,000,000 | reported | |
| FY 2014 | 2014-12-31 | $19,960,000,000 | reported |
AbbVie Inc. · CIK 1551152 · Engraved from SEC EDGAR
